Biotin Med Booster 112.2 mg / 170 g Powder For Solution is a Health Canada–registered veterinary drug (DIN 01985248) held by Bio Agri Mix Lp, containing Folic Acid. Health Canada lists its status as Cancelled Post Market (status date 02 Jun 2020). Nexara Health has matched 452 registrations of Folic Acid across 26 other regulated markets.

Health Canada registration

Folic Acid registered in other markets

452 registrations of the same molecule in 26 national registries outside Canada (first 120 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

See every manufacturer of Folic Acid worldwide →

Regulator price references for Folic Acid

Published list or reimbursement prices for Folic Acid presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Biotin Med Booster (DIN 01985248) marketed in Canada?

No. Health Canada lists DIN 01985248 as Cancelled Post Market as of 02 Jun 2020.

Who holds the Canadian licence for this product?

Bio Agri Mix Lp is the company of record in the Health Canada Drug Product Database.

Is Folic Acid registered outside Canada?

Yes — Nexara Health has matched 452 registrations in 26 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 01985248, status date 2020-06-02; national medicine registries: AIFA liste A/H, ANMDMR nomenclator, ARCSA registro sanitario, BDA, CMED, CNS liste positive, DH Drug Office, DoH SEP database, eEKO (Erstattungskodex), EMA centrally authorised, HPRA, LINAME (formulary), Medicines Authority, MISPAS, MoH deltio timwn, NHRA, NPRA, PBS, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: AIFA liste A/H, CMED, EDE, eEKO (Erstattungskodex), MoH deltio timwn, NHRA, PBS. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 01985248, status date 2020-06-02; national medicine registries: AIFA liste A/H, ANMDMR nomenclator, ARCSA registro sanitario, BDA, CMED, CNS liste positive, DH Drug Office, DoH SEP database, eEKO (Erstattungskodex), EMA centrally authorised, HPRA, LINAME (formulary), Medicines Authority, MISPAS, MoH deltio timwn, NHRA, NPRA, PBS, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: AIFA liste A/H, CMED, EDE, eEKO (Erstattungskodex), MoH deltio timwn, NHRA, PBS.

Health Canada Drug Product Database (DPD), DIN 01985248, status date 2020-06-02; national medicine registries: AIFA liste A/H, ANMDMR nomenclator, ARCSA registro sanitario, BDA, CMED, CNS liste positive, DH Drug Office, DoH SEP database, eEKO (Erstattungskodex), EMA centrally authorised, HPRA, LINAME (formulary), Medicines Authority, MISPAS, MoH deltio timwn, NHRA, NPRA, PBS, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: AIFA liste A/H, CMED, EDE, eEKO (Erstattungskodex), MoH deltio timwn, NHRA, PBS. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.